Related Experiment Video
Updated: Mar 11, 2026

26:48
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
Published on: July 4, 2007
18.9K
Steroid Responsive Mononeuritis Multiplex in the Cronkhite-Canada Syndrome
1Department of Neurology, National Neuroscience Institute, Singapore General Hospital, Singapore; Due-NUS Medical School, Singapore.
Frontiers in Neurology
|December 1, 2016
Summary
Cronkhite-Canada syndrome (CCS) is a rare gastrointestinal disorder. This case highlights a potential autoimmune link in CCS, suggested by nerve damage and response to steroids.
Area of Science:
- Gastroenterology
- Neurology
- Autoimmunology
Background:
- Cronkhite-Canada syndrome (CCS) is a rare disorder characterized by gastrointestinal polyposis, alopecia, hyperpigmentation, and onychodystrophy.
- The etiology of CCS remains largely unknown.
- This report details a unique presentation of CCS.
Observation:
- A patient presented with Cronkhite-Canada syndrome (CCS).
- Concurrently, the patient exhibited mononeuritis multiplex, a form of nerve damage.
- Electrophysiological studies were conducted.
Findings:
- The findings suggest a potential autoimmune basis for CCS.
- Nerve conduction studies indicated peripheral neuropathy.
- The patient's response to steroid treatment supports an autoimmune hypothesis.
Implications:
- This case expands the understanding of CCS manifestations.
- It suggests that autoimmune mechanisms may play a role in CCS pathogenesis.
- Further research into autoimmune pathways in CCS is warranted.
Related Concept Videos
Hypersensitivity Reactions: Immune-Complex Reactions
81
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
81
Autoimmune Disorders
2.1K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.1K
Myasthenia Gravis: Diagnostic Tests
2.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
2.9K
Myocarditis II: Clinical Features and Diagnostic Tests
395
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
395
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K

